Angiogenesis plays a role in tumor growth, and angiogenic growth factors such as vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) are elevated in patients with HCC [15–17]. This evidence concerns the gene VEGFA and hepatocellular carcinoma.